Page 16 - Element Materials Technology News Today

Element Materials Technology is one of the world's leading global providers of testing, inspection and certification services for a diverse range of products and technologies.

Singaporean state-owned investor Temasek Holdings Pte is nearing a deal to buy testing company Element Materials Technology from buyout firm Bridgepoint Group PLC for almost US$7 billion, people familiar with the matter said. Temasek, which is a minority owner in the business, could announce an agreement within one week, said the people, who asked not to be identified because discussions are private. UK-listed private equity firm Bridgepoint reportedly began exploring a sale late last year. The ...

SINGAPORE (Reuters) -Singapore's Temasek Holdings has agreed to buy Element Materials Technology for about $7 billion, as it sees an opportunity to boost growth at the testing and inspection services provider, two sources familiar with the matter said.

(Bloomberg) -- Inflexion Private Equity Partners is considering options for Radius Payment Solutions, including a sale that could value the U.K. fuel cards and telematics firm at about 2 billion pounds ($2.7 billion), people familiar with the matter said.

Element further expands its Life Sciences testing business with additional pharmaceutical and biotech testing capabilities in North America and Europe London, UK – January 14, 2022 – Element Materials Technology (Element) completed its sixth life sciences-focused acquisition of 2021, with the formal...

Element Materials Technology operates more than 30 laboratories in the U.S.

Element Materials Technology (Element) has partnered with Rolls-Royce at its Warwick laboratory to introduce spin testing capabilities in the UK.

Electrical & Electronics Testing, Inspection & Certification Market SWOT Analysis by Size, Status and Forecast to 2022-2028

Electrical & Electronics Testing, Inspection & Certification Market SWOT Analysis by Size, Status and Forecast to 2022-2028

The deal allows Element the expertise and capability for pharmaceutical and biopharmaceutical customers.